The Global Human Chorionic Gonadotropin (HCG) Market Size was estimated at USD 801.20 million in 2023 and is projected to reach USD 1175.66 million by 2029, exhibiting a CAGR of 6.60% during the forecast period.
The USA market for Global Human Chorionic Gonadotropin (HCG) Market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Human Chorionic Gonadotropin (HCG) Market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Human Chorionic Gonadotropin (HCG) Market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Report Overview:
Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology.
This report provides a deep insight into the global Human Chorionic Gonadotropin (HCG) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Chorionic Gonadotropin (HCG) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Chorionic Gonadotropin (HCG) market in any manner.
Global Human Chorionic Gonadotropin (HCG) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- EMD Serono, Inc
- Ferring B.V
- Merck & Co., Inc
- Bristol Myers Squibb Company
- Fresenius Kabi AG
- Scripps Laboratories
- Leebio
- Kamiya Biomedical Company
- Sanzyme
- Cigna
- LUPIN
- Sun Pharmaceutical Industries Ltd
- Serum Institute of India Pvt. Ltd
- VHB Medi Sciences Limited
- Zydus Lifesciences Ltd
- Corona Remedies Pvt. Ltd.
Market Segmentation (by Type)
- Natural Source Extraction
- Recombinant DNA Technology
Market Segmentation (by Application)
- Female Infertility Treatment
- Oligospermic Treatment
- Cryptorchidism Treatment
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Human Chorionic Gonadotropin (HCG) Market
- Overview of the regional outlook of the Human Chorionic Gonadotropin (HCG) Market:
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Human Chorionic Gonadotropin (HCG) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Chorionic Gonadotropin (HCG)
1.2 Key Market Segments
1.2.1 Human Chorionic Gonadotropin (HCG) Segment by Type
1.2.2 Human Chorionic Gonadotropin (HCG) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Human Chorionic Gonadotropin (HCG) Market Overview
2.1 Global Market Overview
2.1.1 Global Human Chorionic Gonadotropin (HCG) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Human Chorionic Gonadotropin (HCG) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Human Chorionic Gonadotropin (HCG) Market Competitive Landscape
3.1 Global Human Chorionic Gonadotropin (HCG) Sales by Manufacturers (2019-2024)
3.2 Global Human Chorionic Gonadotropin (HCG) Revenue Market Share by Manufacturers (2019-2024)
3.3 Human Chorionic Gonadotropin (HCG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Chorionic Gonadotropin (HCG) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Human Chorionic Gonadotropin (HCG) Sales Sites, Area Served, Product Type
3.6 Human Chorionic Gonadotropin (HCG) Market Competitive Situation and Trends
3.6.1 Human Chorionic Gonadotropin (HCG) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Chorionic Gonadotropin (HCG) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Human Chorionic Gonadotropin (HCG) Industry Chain Analysis
4.1 Human Chorionic Gonadotropin (HCG) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Chorionic Gonadotropin (HCG) Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Human Chorionic Gonadotropin (HCG) Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2019-2024)
6.3 Global Human Chorionic Gonadotropin (HCG) Market Size Market Share by Type (2019-2024)
6.4 Global Human Chorionic Gonadotropin (HCG) Price by Type (2019-2024)
7 Human Chorionic Gonadotropin (HCG) Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Chorionic Gonadotropin (HCG) Market Sales by Application (2019-2024)
7.3 Global Human Chorionic Gonadotropin (HCG) Market Size (M USD) by Application (2019-2024)
7.4 Global Human Chorionic Gonadotropin (HCG) Sales Growth Rate by Application (2019-2024)
8 Human Chorionic Gonadotropin (HCG) Market Segmentation by Region
8.1 Global Human Chorionic Gonadotropin (HCG) Sales by Region
8.1.1 Global Human Chorionic Gonadotropin (HCG) Sales by Region
8.1.2 Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Region
8.2 North America
8.2.1 North America Human Chorionic Gonadotropin (HCG) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Chorionic Gonadotropin (HCG) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Chorionic Gonadotropin (HCG) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 EMD Serono, Inc
9.1.1 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Basic Information
9.1.2 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product Overview
9.1.3 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product Market Performance
9.1.4 EMD Serono, Inc Business Overview
9.1.5 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) SWOT Analysis
9.1.6 EMD Serono, Inc Recent Developments
9.2 Ferring B.V
9.2.1 Ferring B.V Human Chorionic Gonadotropin (HCG) Basic Information
9.2.2 Ferring B.V Human Chorionic Gonadotropin (HCG) Product Overview
9.2.3 Ferring B.V Human Chorionic Gonadotropin (HCG) Product Market Performance
9.2.4 Ferring B.V Business Overview
9.2.5 Ferring B.V Human Chorionic Gonadotropin (HCG) SWOT Analysis
9.2.6 Ferring B.V Recent Developments
9.3 Merck and Co., Inc
9.3.1 Merck and Co., Inc Human Chorionic Gonadotropin (HCG) Basic Information
9.3.2 Merck and Co., Inc Human Chorionic Gonadotropin (HCG) Product Overview
9.3.3 Merck and Co., Inc Human Chorionic Gonadotropin (HCG) Product Market Performance
9.3.4 Merck and Co., Inc Human Chorionic Gonadotropin (HCG) SWOT Analysis
9.3.5 Merck and Co., Inc Business Overview
9.3.6 Merck and Co., Inc Recent Developments
9.4 Bristol Myers Squibb Company
9.4.1 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Basic Information
9.4.2 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product Overview
9.4.3 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product Market Performance
9.4.4 Bristol Myers Squibb Company Business Overview
9.4.5 Bristol Myers Squibb Company Recent Developments
9.5 Fresenius Kabi AG
9.5.1 Fresenius Kabi AG Human Chorionic Gonadotropin (HCG) Basic Information
9.5.2 Fresenius Kabi AG Human Chorionic Gonadotropin (HCG) Product Overview
9.5.3 Fresenius Kabi AG Human Chorionic Gonadotropin (HCG) Product Market Performance
9.5.4 Fresenius Kabi AG Business Overview
9.5.5 Fresenius Kabi AG Recent Developments
9.6 Scripps Laboratories
9.6.1 Scripps Laboratories Human Chorionic Gonadotropin (HCG) Basic Information
9.6.2 Scripps Laboratories Human Chorionic Gonadotropin (HCG) Product Overview
9.6.3 Scripps Laboratories Human Chorionic Gonadotropin (HCG) Product Market Performance
9.6.4 Scripps Laboratories Business Overview
9.6.5 Scripps Laboratories Recent Developments
9.7 Leebio
9.7.1 Leebio Human Chorionic Gonadotropin (HCG) Basic Information
9.7.2 Leebio Human Chorionic Gonadotropin (HCG) Product Overview
9.7.3 Leebio Human Chorionic Gonadotropin (HCG) Product Market Performance
9.7.4 Leebio Business Overview
9.7.5 Leebio Recent Developments
9.8 Kamiya Biomedical Company
9.8.1 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Basic Information
9.8.2 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product Overview
9.8.3 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product Market Performance
9.8.4 Kamiya Biomedical Company Business Overview
9.8.5 Kamiya Biomedical Company Recent Developments
9.9 Sanzyme
9.9.1 Sanzyme Human Chorionic Gonadotropin (HCG) Basic Information
9.9.2 Sanzyme Human Chorionic Gonadotropin (HCG) Product Overview
9.9.3 Sanzyme Human Chorionic Gonadotropin (HCG) Product Market Performance
9.9.4 Sanzyme Business Overview
9.9.5 Sanzyme Recent Developments
9.10 Cigna
9.10.1 Cigna Human Chorionic Gonadotropin (HCG) Basic Information
9.10.2 Cigna Human Chorionic Gonadotropin (HCG) Product Overview
9.10.3 Cigna Human Chorionic Gonadotropin (HCG) Product Market Performance
9.10.4 Cigna Business Overview
9.10.5 Cigna Recent Developments
9.11 LUPIN
9.11.1 LUPIN Human Chorionic Gonadotropin (HCG) Basic Information
9.11.2 LUPIN Human Chorionic Gonadotropin (HCG) Product Overview
9.11.3 LUPIN Human Chorionic Gonadotropin (HCG) Product Market Performance
9.11.4 LUPIN Business Overview
9.11.5 LUPIN Recent Developments
9.12 Sun Pharmaceutical Industries Ltd
9.12.1 Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (HCG) Basic Information
9.12.2 Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (HCG) Product Overview
9.12.3 Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (HCG) Product Market Performance
9.12.4 Sun Pharmaceutical Industries Ltd Business Overview
9.12.5 Sun Pharmaceutical Industries Ltd Recent Developments
9.13 Serum Institute of India Pvt. Ltd
9.13.1 Serum Institute of India Pvt. Ltd Human Chorionic Gonadotropin (HCG) Basic Information
9.13.2 Serum Institute of India Pvt. Ltd Human Chorionic Gonadotropin (HCG) Product Overview
9.13.3 Serum Institute of India Pvt. Ltd Human Chorionic Gonadotropin (HCG) Product Market Performance
9.13.4 Serum Institute of India Pvt. Ltd Business Overview
9.13.5 Serum Institute of India Pvt. Ltd Recent Developments
9.14 VHB Medi Sciences Limited
9.14.1 VHB Medi Sciences Limited Human Chorionic Gonadotropin (HCG) Basic Information
9.14.2 VHB Medi Sciences Limited Human Chorionic Gonadotropin (HCG) Product Overview
9.14.3 VHB Medi Sciences Limited Human Chorionic Gonadotropin (HCG) Product Market Performance
9.14.4 VHB Medi Sciences Limited Business Overview
9.14.5 VHB Medi Sciences Limited Recent Developments
9.15 Zydus Lifesciences Ltd
9.15.1 Zydus Lifesciences Ltd Human Chorionic Gonadotropin (HCG) Basic Information
9.15.2 Zydus Lifesciences Ltd Human Chorionic Gonadotropin (HCG) Product Overview
9.15.3 Zydus Lifesciences Ltd Human Chorionic Gonadotropin (HCG) Product Market Performance
9.15.4 Zydus Lifesciences Ltd Business Overview
9.15.5 Zydus Lifesciences Ltd Recent Developments
9.16 Corona Remedies Pvt. Ltd.
9.16.1 Corona Remedies Pvt. Ltd. Human Chorionic Gonadotropin (HCG) Basic Information
9.16.2 Corona Remedies Pvt. Ltd. Human Chorionic Gonadotropin (HCG) Product Overview
9.16.3 Corona Remedies Pvt. Ltd. Human Chorionic Gonadotropin (HCG) Product Market Performance
9.16.4 Corona Remedies Pvt. Ltd. Business Overview
9.16.5 Corona Remedies Pvt. Ltd. Recent Developments
10 Human Chorionic Gonadotropin (HCG) Market Forecast by Region
10.1 Global Human Chorionic Gonadotropin (HCG) Market Size Forecast
10.2 Global Human Chorionic Gonadotropin (HCG) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Chorionic Gonadotropin (HCG) Market Size Forecast by Country
10.2.3 Asia Pacific Human Chorionic Gonadotropin (HCG) Market Size Forecast by Region
10.2.4 South America Human Chorionic Gonadotropin (HCG) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Chorionic Gonadotropin (HCG) by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Human Chorionic Gonadotropin (HCG) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Human Chorionic Gonadotropin (HCG) by Type (2025-2030)
11.1.2 Global Human Chorionic Gonadotropin (HCG) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Human Chorionic Gonadotropin (HCG) by Type (2025-2030)
11.2 Global Human Chorionic Gonadotropin (HCG) Market Forecast by Application (2025-2030)
11.2.1 Global Human Chorionic Gonadotropin (HCG) Sales (Kilotons) Forecast by Application
11.2.2 Global Human Chorionic Gonadotropin (HCG) Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Human Chorionic Gonadotropin (HCG) Market Size Comparison by Region (M USD)
Table 5. Global Human Chorionic Gonadotropin (HCG) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Human Chorionic Gonadotropin (HCG) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Human Chorionic Gonadotropin (HCG) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Chorionic Gonadotropin (HCG) as of 2022)
Table 10. Global Market Human Chorionic Gonadotropin (HCG) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Human Chorionic Gonadotropin (HCG) Sales Sites and Area Served
Table 12. Manufacturers Human Chorionic Gonadotropin (HCG) Product Type
Table 13. Global Human Chorionic Gonadotropin (HCG) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Human Chorionic Gonadotropin (HCG)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Human Chorionic Gonadotropin (HCG) Market Challenges
Table 22. Global Human Chorionic Gonadotropin (HCG) Sales by Type (Kilotons)
Table 23. Global Human Chorionic Gonadotropin (HCG) Market Size by Type (M USD)
Table 24. Global Human Chorionic Gonadotropin (HCG) Sales (Kilotons) by Type (2019-2024)
Table 25. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Type (2019-2024)
Table 26. Global Human Chorionic Gonadotropin (HCG) Market Size (M USD) by Type (2019-2024)
Table 27. Global Human Chorionic Gonadotropin (HCG) Market Size Share by Type (2019-2024)
Table 28. Global Human Chorionic Gonadotropin (HCG) Price (USD/Ton) by Type (2019-2024)
Table 29. Global Human Chorionic Gonadotropin (HCG) Sales (Kilotons) by Application
Table 30. Global Human Chorionic Gonadotropin (HCG) Market Size by Application
Table 31. Global Human Chorionic Gonadotropin (HCG) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2019-2024)
Table 33. Global Human Chorionic Gonadotropin (HCG) Sales by Application (2019-2024) & (M USD)
Table 34. Global Human Chorionic Gonadotropin (HCG) Market Share by Application (2019-2024)
Table 35. Global Human Chorionic Gonadotropin (HCG) Sales Growth Rate by Application (2019-2024)
Table 36. Global Human Chorionic Gonadotropin (HCG) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Region (2019-2024)
Table 38. North America Human Chorionic Gonadotropin (HCG) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Human Chorionic Gonadotropin (HCG) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Human Chorionic Gonadotropin (HCG) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales by Region (2019-2024) & (Kilotons)
Table 43. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Basic Information
Table 44. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product Overview
Table 45. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. EMD Serono, Inc Business Overview
Table 47. EMD Serono, Inc Human Chorionic Gonadotropin (HCG) SWOT Analysis
Table 48. EMD Serono, Inc Recent Developments
Table 49. Ferring B.V Human Chorionic Gonadotropin (HCG) Basic Information
Table 50. Ferring B.V Human Chorionic Gonadotropin (HCG) Product Overview
Table 51. Ferring B.V Human Chorionic Gonadotropin (HCG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Ferring B.V Business Overview
Table 53. Ferring B.V Human Chorionic Gonadotropin (HCG) SWOT Analysis
Table 54. Ferring B.V Recent Developments
Table 55. Merck and Co., Inc Human Chorionic Gonadotropin (HCG) Basic Information
Table 56. Merck and Co., Inc Human Chorionic Gonadotropin (HCG) Product Overview
Table 57. Merck and Co., Inc Human Chorionic Gonadotropin (HCG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Merck and Co., Inc Human Chorionic Gonadotropin (HCG) SWOT Analysis
Table 59. Merck and Co., Inc Business Overview
Table 60. Merck and Co., Inc Recent Developments
Table 61. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Basic Information
Table 62. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product Overview
Table 63. Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Bristol Myers Squibb Company Business Overview
Table 65. Bristol Myers Squibb Company Recent Developments
Table 66. Fresenius Kabi AG Human Chorionic Gonadotropin (HCG) Basic Information
Table 67. Fresenius Kabi AG Human Chorionic Gonadotropin (HCG) Product Overview
Table 68. Fresenius Kabi AG Human Chorionic Gonadotropin (HCG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Fresenius Kabi AG Business Overview
Table 70. Fresenius Kabi AG Recent Developments
Table 71. Scripps Laboratories Human Chorionic Gonadotropin (HCG) Basic Information
Table 72. Scripps Laboratories Human Chorionic Gonadotropin (HCG) Product Overview
Table 73. Scripps Laboratories Human Chorionic Gonadotropin (HCG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Scripps Laboratories Business Overview
Table 75. Scripps Laboratories Recent Developments
Table 76. Leebio Human Chorionic Gonadotropin (HCG) Basic Information
Table 77. Leebio Human Chorionic Gonadotropin (HCG) Product Overview
Table 78. Leebio Human Chorionic Gonadotropin (HCG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Leebio Business Overview
Table 80. Leebio Recent Developments
Table 81. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Basic Information
Table 82. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product Overview
Table 83. Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Kamiya Biomedical Company Business Overview
Table 85. Kamiya Biomedical Company Recent Developments
Table 86. Sanzyme Human Chorionic Gonadotropin (HCG) Basic Information
Table 87. Sanzyme Human Chorionic Gonadotropin (HCG) Product Overview
Table 88. Sanzyme Human Chorionic Gonadotropin (HCG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Sanzyme Business Overview
Table 90. Sanzyme Recent Developments
Table 91. Cigna Human Chorionic Gonadotropin (HCG) Basic Information
Table 92. Cigna Human Chorionic Gonadotropin (HCG) Product Overview
Table 93. Cigna Human Chorionic Gonadotropin (HCG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Cigna Business Overview
Table 95. Cigna Recent Developments
Table 96. LUPIN Human Chorionic Gonadotropin (HCG) Basic Information
Table 97. LUPIN Human Chorionic Gonadotropin (HCG) Product Overview
Table 98. LUPIN Human Chorionic Gonadotropin (HCG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. LUPIN Business Overview
Table 100. LUPIN Recent Developments
Table 101. Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (HCG) Basic Information
Table 102. Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (HCG) Product Overview
Table 103. Sun Pharmaceutical Industries Ltd Human Chorionic Gonadotropin (HCG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Sun Pharmaceutical Industries Ltd Business Overview
Table 105. Sun Pharmaceutical Industries Ltd Recent Developments
Table 106. Serum Institute of India Pvt. Ltd Human Chorionic Gonadotropin (HCG) Basic Information
Table 107. Serum Institute of India Pvt. Ltd Human Chorionic Gonadotropin (HCG) Product Overview
Table 108. Serum Institute of India Pvt. Ltd Human Chorionic Gonadotropin (HCG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Serum Institute of India Pvt. Ltd Business Overview
Table 110. Serum Institute of India Pvt. Ltd Recent Developments
Table 111. VHB Medi Sciences Limited Human Chorionic Gonadotropin (HCG) Basic Information
Table 112. VHB Medi Sciences Limited Human Chorionic Gonadotropin (HCG) Product Overview
Table 113. VHB Medi Sciences Limited Human Chorionic Gonadotropin (HCG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. VHB Medi Sciences Limited Business Overview
Table 115. VHB Medi Sciences Limited Recent Developments
Table 116. Zydus Lifesciences Ltd Human Chorionic Gonadotropin (HCG) Basic Information
Table 117. Zydus Lifesciences Ltd Human Chorionic Gonadotropin (HCG) Product Overview
Table 118. Zydus Lifesciences Ltd Human Chorionic Gonadotropin (HCG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Zydus Lifesciences Ltd Business Overview
Table 120. Zydus Lifesciences Ltd Recent Developments
Table 121. Corona Remedies Pvt. Ltd. Human Chorionic Gonadotropin (HCG) Basic Information
Table 122. Corona Remedies Pvt. Ltd. Human Chorionic Gonadotropin (HCG) Product Overview
Table 123. Corona Remedies Pvt. Ltd. Human Chorionic Gonadotropin (HCG) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Corona Remedies Pvt. Ltd. Business Overview
Table 125. Corona Remedies Pvt. Ltd. Recent Developments
Table 126. Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Human Chorionic Gonadotropin (HCG) Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Human Chorionic Gonadotropin (HCG) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Human Chorionic Gonadotropin (HCG) Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Human Chorionic Gonadotropin (HCG) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Human Chorionic Gonadotropin (HCG) Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Human Chorionic Gonadotropin (HCG) Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Human Chorionic Gonadotropin (HCG) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Human Chorionic Gonadotropin (HCG) Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Human Chorionic Gonadotropin (HCG) Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Human Chorionic Gonadotropin (HCG) Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Human Chorionic Gonadotropin (HCG) Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Human Chorionic Gonadotropin (HCG) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Human Chorionic Gonadotropin (HCG) Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Human Chorionic Gonadotropin (HCG) Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Human Chorionic Gonadotropin (HCG)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Human Chorionic Gonadotropin (HCG) Market Size (M USD), 2019-2030
Figure 5. Global Human Chorionic Gonadotropin (HCG) Market Size (M USD) (2019-2030)
Figure 6. Global Human Chorionic Gonadotropin (HCG) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Human Chorionic Gonadotropin (HCG) Market Size by Country (M USD)
Figure 11. Human Chorionic Gonadotropin (HCG) Sales Share by Manufacturers in 2023
Figure 12. Global Human Chorionic Gonadotropin (HCG) Revenue Share by Manufacturers in 2023
Figure 13. Human Chorionic Gonadotropin (HCG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Human Chorionic Gonadotropin (HCG) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Human Chorionic Gonadotropin (HCG) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Human Chorionic Gonadotropin (HCG) Market Share by Type
Figure 18. Sales Market Share of Human Chorionic Gonadotropin (HCG) by Type (2019-2024)
Figure 19. Sales Market Share of Human Chorionic Gonadotropin (HCG) by Type in 2023
Figure 20. Market Size Share of Human Chorionic Gonadotropin (HCG) by Type (2019-2024)
Figure 21. Market Size Market Share of Human Chorionic Gonadotropin (HCG) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Human Chorionic Gonadotropin (HCG) Market Share by Application
Figure 24. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Application (2019-2024)
Figure 25. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Application in 2023
Figure 26. Global Human Chorionic Gonadotropin (HCG) Market Share by Application (2019-2024)
Figure 27. Global Human Chorionic Gonadotropin (HCG) Market Share by Application in 2023
Figure 28. Global Human Chorionic Gonadotropin (HCG) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Human Chorionic Gonadotropin (HCG) Sales Market Share by Region (2019-2024)
Figure 30. North America Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Human Chorionic Gonadotropin (HCG) Sales Market Share by Country in 2023
Figure 32. U.S. Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Human Chorionic Gonadotropin (HCG) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Human Chorionic Gonadotropin (HCG) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Human Chorionic Gonadotropin (HCG) Sales Market Share by Country in 2023
Figure 37. Germany Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Human Chorionic Gonadotropin (HCG) Sales Market Share by Region in 2023
Figure 44. China Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (Kilotons)
Figure 50. South America Human Chorionic Gonadotropin (HCG) Sales Market Share by Country in 2023
Figure 51. Brazil Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Human Chorionic Gonadotropin (HCG) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Human Chorionic Gonadotropin (HCG) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Human Chorionic Gonadotropin (HCG) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Human Chorionic Gonadotropin (HCG) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Human Chorionic Gonadotropin (HCG) Market Share Forecast by Type (2025-2030)
Figure 65. Global Human Chorionic Gonadotropin (HCG) Sales Forecast by Application (2025-2030)
Figure 66. Global Human Chorionic Gonadotropin (HCG) Market Share Forecast by Application (2025-2030)
